Details

Autor(en) / Beteiligte

• Xia, Feng‐Wei
• Guo, Bing‐Wei
• Zhao, Yu
• Wang, Jia‐Li
• Chen, Yuan
• Pan, Xiu
• Li, Xin
• Song, Jia‐Xing
• Wan, Yu
• Feng, Shun
• Wu, Ming‐Yu

Titel

Type I Photosensitizer Targeting Glycans: Overcoming Biofilm Resistance by Inhibiting the Two‐Component System, Quorum Sensing, and Multidrug Efflux

Ist Teil von

• Advanced materials (Weinheim), 2023-12, Vol.35 (52), p.e2309797-n/a

Ort / Verlag

Germany: Wiley Subscription Services, Inc

Erscheinungsjahr

2023

Quelle

Access via Wiley Online Library

Beschreibungen/Notizen

• Stubborn biofilm infections pose serious threats to human health due to the persistence, recurrence, and dramatically magnified antibiotic resistance. Photodynamic therapy has emerged as a promising approach to combat biofilm. Nevertheless, how to inhibit the bacterial signal transduction system and the efflux pump to conquer biofilm recurrence and resistance remains a challenging and unaddressed issue. Herein, a boric acid‐functionalized lipophilic cationic type I photosensitizer, ACR‐DMP, is developed, which efficiently generates •OH to overcome the hypoxic microenvironment and photodynamically eradicates methicillin‐resistant Staphylococcus aureus (MRSA) and biofilms. Furthermore, it not only alters membrane potential homeostasis and osmotic pressure balance due to its strong binding ability with plasma membrane but also inhibits quorum sensing and the two‐component system, reduces virulence factors, and regulates the activity of the drug efflux pump attributed to the glycan‐targeting ability, helping to prevent biofilm recurrence and conquer biofilm resistance. In vivo, ACR‐DMP successfully obliterates MRSA biofilms attached to implanted medical catheters, alleviates inflammation, and promotes vascularization, thereby combating infections and accelerating wound healing. This work not only provides an efficient strategy to combat stubborn biofilm infections and bacterial multidrug resistance but also offers systematic guidance for the rational design of next‐generation advanced antimicrobial materials. A glycan‐targeting type I photosensitizer is developed to fight against stubborn biofilms. ACR‐DMP has high extracellular polymer penetrability and overcomes the hypoxic microenvironment, which therefore efficiently eradicates biofilm in vitro and in vivo. It not only changes the membrane potential homeostasis and the osmotic pressure balance, but also inhibits quorum sensing, two‐component system, and efflux pump to conquer biofilm resistance.